BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1200 related articles for article (PubMed ID: 10359558)

  • 1. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
    Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
    J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).
    Aoyama T; Peters JM; Iritani N; Nakajima T; Furihata K; Hashimoto T; Gonzalez FJ
    J Biol Chem; 1998 Mar; 273(10):5678-84. PubMed ID: 9488698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice.
    Erol E; Kumar LS; Cline GW; Shulman GI; Kelly DP; Binas B
    FASEB J; 2004 Feb; 18(2):347-9. PubMed ID: 14656998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders.
    Leone TC; Weinheimer CJ; Kelly DP
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7473-8. PubMed ID: 10377439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
    Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
    J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
    Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice.
    Wan YJ; Cai Y; Lungo W; Fu P; Locker J; French S; Sucov HM
    J Biol Chem; 2000 Sep; 275(36):28285-90. PubMed ID: 10866995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.
    Hashimoto T; Fujita T; Usuda N; Cook W; Qi C; Peters JM; Gonzalez FJ; Yeldandi AV; Rao MS; Reddy JK
    J Biol Chem; 1999 Jul; 274(27):19228-36. PubMed ID: 10383430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation.
    Gremlich S; Nolan C; Roduit R; Burcelin R; Peyot ML; Delghingaro-Augusto V; Desvergne B; Michalik L; Prentki M; Wahli W
    Endocrinology; 2005 Jan; 146(1):375-82. PubMed ID: 15459119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
    Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
    Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver.
    Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H
    Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fatty acids and growth hormone on liver fatty acid binding protein and PPARalpha in rat liver.
    Carlsson L; Lindén D; Jalouli M; Oscarsson J
    Am J Physiol Endocrinol Metab; 2001 Oct; 281(4):E772-81. PubMed ID: 11551854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats.
    Moya-Camarena SY; Van den Heuvel JP; Belury MA
    Biochim Biophys Acta; 1999 Jan; 1436(3):331-42. PubMed ID: 9989264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation.
    Nanji AA; Dannenberg AJ; Jokelainen K; Bass NM
    J Pharmacol Exp Ther; 2004 Jul; 310(1):417-24. PubMed ID: 15016835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
    El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
    Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha.
    Ren B; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
    J Biol Chem; 1997 Oct; 272(43):26827-32. PubMed ID: 9341113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the expression of peroxisome proliferator-activated receptor-dependent genes through disproportional expression of two subtypes in the small intestine.
    Mochizuki K; Suruga K; Kitagawa M; Takase S; Goda T
    Arch Biochem Biophys; 2001 May; 389(1):41-8. PubMed ID: 11370670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.
    Yu S; Matsusue K; Kashireddy P; Cao WQ; Yeldandi V; Yeldandi AV; Rao MS; Gonzalez FJ; Reddy JK
    J Biol Chem; 2003 Jan; 278(1):498-505. PubMed ID: 12401792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.